Moreover, hyperinsulinemia may exert potent proliferative effects, either directly or by cross-reacting with the insulin-like growth factor 1 (IGF-1) receptor [14, 106] thus increasing the risk of cancer in obesity and type 2 diabetes. The gene discussed is IGF1; the disease is Hyperinsulinemia.